Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
BEIJING,Nov. 16,2024-- "FromChancay to Shanghai" has become a popular slogan in Peru as the Chancay Port,a flagship project of the China-proposed Belt and Road Initiative (BRI),held a grand
BEIJING,Nov. 16,2024-- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital"),an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China,announced that it
SEOUL,South Korea,Nov. 16,2024-- In 2023,d\'Alba achieved a major milestone as Korea\'s top revenue-generating independent skincare brand. This accomplishment,in a market heavily populated,has solidif
HANGZHOU,China,Nov. 14,2024-- Youdao,Inc. ("Youdao" or the "Company") (NYSE: DAO),an intelligent learning company with industry-leading technology in China,today announced its unau
BANGKOK,Nov. 14,2024-- The highly anticipated firstChina-ASEAN AI-Empower Cross-Border Digital Marketing Competition was launched at Chulalongkorn University in Bangkok,Thailand on the morning of Nove
KUALA LUMPUR,Malaysia,Nov. 14,2024--The Contact Centre Association of Malaysia (CCAM) today proudly launched CX Malaysia,a chapter dedicated at elevating customer experience (CX) standards in Malaysia
Lillytodrivenext-generationAI-powereddigitalhealthtechnologyresearchinSingapore SINGAPORE,Nov. 14,2024-- Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP),a wholly owned subsidiar
SINGAPORE,Nov. 14,2024-- BB Energy andSGTraDex renew strategic partnership to advance digital borrowing base financing across Asia. This continued collaboration underscores both companies\' commitment
Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study ofuliledlimab in first-line mNSCLC in 1H 2025
CHONGQING,China,Nov. 14,2024-- A news report from iChongqing: On November 12,the 6thChina-ASEAN Legal Cooperation Forum kicked off in Southwest China\'s Chongqing municipality.
© OfficialAffairs
